XETRA : 6MK.DE

Merck & Co., Inc.

$115.14 EUR

$0.22 (0.19%)

Volume
340
Average Volume
1.53K
Market Capitalization
$284.38B
P/E Ratio
36.82
Dividend Yield
2.56%
Price Target
Year High
$115.50
Year Low
$66.40
Day High
—
Day Low
—
Payout Ratio
$0.92
Current Ratio
$1.30
Company Overview

XETRA

Robert Davis

Drug Manufacturers - General

Healthcare

6MK.DE

73000

US

EUR

https://www.merck.com

908 740 4000

58933Y105

N/A

Liquidity Metrics

1.07

1.30

1.06

0.20

0.92

Sales & Valuation

$65.02B

4.94

7.06

22.93

5.71

Profitability

$7.28

$18.26B

13.62%

17.73%

17.93%

6.94%

P/E Metrics

36.82

-0.76

-0.76

Analyst Price Target & Rating

Neutral

3/5

38 Analysts

%

Financial Health Scores

4.09

6/9

$8.04B

$128.2B

$82.44B

$16.48B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Richard R. DeLuca Jr. Executive Vice President & President of Merck Animal Health
Dalton E. Smart Senior Vice President of Finance, Principal Accounting Officer & Global Controller
Peter Dannenbaum Vice President of Investor Relations
Robert Davis Chairman, President & Chief Executive Officer
Betty D. Larson Executive Vice President & Chief Human Resources Officer
Caroline Litchfield Executive Vice President & Chief Financial Officer
Jennifer L. Zachary Executive Vice President & General Counsel
Dean Y. Li Executive Vice President & President of Merck Research Laboratories
Chirfi Guindo Executive Vice President of Strategic Access, Policy & Communications
David Michael Williams Executive Vice President and Chief Information & Digital Officer
Poll Results

No votes yet today — be the first to share your view!

About Merck & Co., Inc. (XETRA:6MK.DE) Stock

Merck & Co., Inc. operates as a leading global healthcare enterprise. Its operations are structured into two primary segments: Pharmaceutical and Animal Health. The Pharmaceutical division is dedicated to offering human health solutions, encompassing prescription medicines for critical therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular health, and diabetes. This segment also provides a suite of vaccine products designed for preventive use across pediatric, adolescent, and adult populations. Conversely, the Animal Health segment is committed to the discovery, development, production, and commercialization of veterinary pharmaceuticals, vaccines, and comprehensive health management solutions. This also extends to sophisticated digitall ... y connected products for identification, traceability, and monitoring of animals. The company's extensive customer base includes drug wholesalers, retail pharmacies, hospitals, and various governmental agencies. It also caters to managed health care providers, such as health maintenance organizations and pharmacy benefit managers, as well as individual physicians, physician distributors, veterinarians, and animal producers. Furthermore, Merck & Co., Inc. actively collaborates with several industry partners, including AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc., to jointly advance and bring to market long-acting treatments for HIV. Established in 1891, the company maintains its corporate headquarters in Kenilworth, New Jersey.

Frequently Asked Questions

What is the current Merck & Co., Inc. (6MK.DE) stock price?

Merck & Co., Inc.(XETRA:6MK.DE) stock price is $115.14 in the last trading session. During the trading session, 6MK.DE stock reached the peak price of $115.5 while $66.4 was the lowest point it dropped to. The percentage change in 6MK.DE stock occurred in the recent session was 0.19% while the dollar amount for the price change in 6MK.DE stock was $0.22.

6MK.DE's industry and sector of operation?

The XETRA listed 6MK.DE is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.

Who are the executives of 6MK.DE?

Richard R. DeLuca Jr. | Executive Vice President & President of Merck Animal Health
Dalton E. Smart | Senior Vice President of Finance, Principal Accounting Officer & Global Controller
Peter Dannenbaum | Vice President of Investor Relations
Robert Davis | Chairman, President & Chief Executive Officer
Betty D. Larson | Executive Vice President & Chief Human Resources Officer

How many employees does 6MK.DE have?

Number of 6MK.DE employees currently stands at 73000. 6MK.DE operates from 126 E. Lincoln Avenue, Rahway, NJ 07033, US.

Link for 6MK.DE official website?

Official Website of 6MK.DE is: https://www.merck.com

How do I contact 6MK.DE?

6MK.DE could be contacted at phone #908 740 4000 and can also be accessed through its website. 6MK.DE operates from 126 E. Lincoln Avenue, Rahway, NJ 07033, US.

How many shares of 6MK.DE are traded daily?

The average number of 6MK.DE shares traded daily for last 3 months was 1.53K.

What is the market cap of 6MK.DE currently?

The market value of 6MK.DE currently stands at $284.38B with its latest stock price at $115.14